About Caplin Point Laboratories Ltd 
Caplin Point Laboratories Ltd
Mid Cap
Pharmaceuticals & Drugs
Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16th, 1990. The Company is a fully integrated Pharma Company and is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market. Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
Company Coordinates 
Company Details
Ashvich Towers 3rd Floor, No 3 Developed Plots Ind Estat Chennai Tamil Nadu : 600096
Registrar Details
Integrated Enterprises (India) Ltd , II Floor , Kences Towers, No 1 Ramakrishna Street, North Usman Road, T Nagar, Chennai
Capital Structure 
Present Equity Capital
INR 15.20 Cr
Number of Shares
7.6 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
16-Jul-2024
7.6
15.20
1400
2
Issued under ESOP Scheme
19-Jun-2024
7.6
15.20
68550
2
Issued under ESOP Scheme
21-Dec-2023
7.59
15.19
1000
2
Issued under ESOP Scheme
11-Oct-2023
7.59
15.19
1000
2
Issued under ESOP Scheme
11-Sep-2023
7.59
15.19
6000
2
Issued under ESOP Scheme
05-Jun-2023
7.59
15.19
12000
2
Issued under ESOP Scheme
11-Apr-2023
7.59
15.18
19000
2
Issued under ESPS
11-Apr-2023
7.59
15.18
19000
2
Issued under ESPS
17-Feb-2023
7.59
15.18
5000
2
Issued under ESOP Scheme
04-Jan-2023
7.59
15.18
5500
2
Issued under ESOP Scheme
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 16 Schemes (1.86%)
FIIs
Held by 126 FIIs (4.86%)
Promoter with highest holding
P Vijayalakshmi (24.71%)
Highest Public shareholder
Uti Small Cap Fund (1.39%)
Individual Investors Holdings
15.77%
Management
Designation
Remuneration
C C Paarthipan
Chairman & Non Executive Dir.
0
D Sathyanarayanan
Independent Non Exe. Director
1.6 lacs
C K Gariyali
Independent Director
1.0 lacs
Deenadayalan Singaram
Independent Non Exe. Director
60.0 k
R Nagendran
Independent Non Exe. Director
40.0 k
Sridhar Ganesan
Non Independent Executive Dire
87.0 lacs
Raw Materials Dashboard 
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Dashboard 
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Export Incentives
15.75
2.93%
Export Incentives
Export Incentives
Revenue and Profits:
Net Sales:
493 Cr
(Quarterly Results - Dec 2024)
Net Profit:
139 Cr
Pharmaceuticals & Drugs
INR 13,910 Cr (Mid Cap)
25.00
33
0.29%
-0.32
19.41%
5.13